EPG Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
EPG Wealth Management's BMY Position: Q3 2026 in Review
EPG Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 2.8% in Q3 2026, buying an estimated $25K and bringing the position to 14,529 shares worth $907K. The position accounts for 0.21% of the portfolio, ranked #113.
EPG Wealth Management first reported a position in BMY in Q4 2019 and has held it in 25 quarters since. 1,630 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- EPG Wealth Management held 14,529 shares of Bristol-Myers Squibb worth $907K as of Q3 2026.
- EPG Wealth Management bought 396 Bristol-Myers Squibb shares in Q3 2026, an estimated $25K.
- Bristol-Myers Squibb made up 0.21% of EPG Wealth Management's portfolio in Q3 2026, its #113 holding.
- EPG Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 25 quarters since.
- 1,630 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on EPG Wealth Management's 13F filing for Q3 2026, filed 3 Nov 2026.